Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

CJC-1295 No DAC Vial Dose Comparison

| Vial Size | Reconstitution Volume | Concentration (mcg/mL) | Dose per Administration | Theoretical Doses per Vial | Practical Doses (accounting for dead volume) | 28-Day Sterility Window Limit ||—|—|—|—|—|—|| 2mg | 2mL | 1000 | 100mcg (0.1mL) | 20 | 18–19 |

This comparison does not assign a generated winner or score.

  • | Vial Size | Reconstitution Volume | Concentration (mcg/mL) | Dose per Administration | Theoretical Doses per Vial | Practical Doses (accounting for dead volume) | 28-Day Sterility Window Limit ||—|—|—|—|—|—|| 2mg | 2mL | 1000 | 100mcg (0.1mL) | 20 | 18–19 | 4 doses if dosed weekly; 12 doses if dosed 3× weekly || 2mg | 2mL | 1000 | 200mcg (0.2mL) | 10 | 9–10 | 4 doses if dosed weekly; 12 doses if dosed 3× weekly || 2mg | 2mL | 1000 | 250mcg (0.25mL) | 8 | 7–8 | 4 doses if dosed weekly; 12 doses if dosed 3× weekly || 5mg | 2mL | 2500 | 250mcg (0.1mL) | 20 | 18–19 | 4 doses if dosed weekly; 12 doses if dosed 3× weekly || 5mg | 5mL | 1000 | 200mcg (0.2mL) | 25 | 23–24 | 4 doses if dosed weekly; 12 doses if dosed 3× weekly || 10mg | 2mL | 5000 | 500mcg (0.1mL) | 20 | 18–19 | 4 doses if dosed weekly; 12 doses if dosed 3× weekly |
More references

Related material